GlassScriptPhysician profile
Angel M Sabo
NPI 1699128538
$5,904.08
in general payments reported to CMS, 2019-2025
36 companies · $967 in 2025
The $967 reported for 2025 was more than what 87% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,301 · 2022: $1,057 · 2023: $1,654 · 2024: $925 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,358 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,357.61 |
| Education | $187.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,464.75 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,037.36 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| United Therapeutics Corporation | $482.50 | 2021-2025 | Tyvaso, Orenitram, Remodulin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.62 | 2021-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Amgen INC. | $300.05 | 2022-2025 | Tezspire |
| Genzyme Corporation | $266.01 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $258.93 | 2021-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $182.36 | 2021-2025 | Uptravi, Opsumit |
| Jazz Pharmaceuticals INC. | $148.56 | 2021-2023 | |
| Genentech USA, INC. | $138.69 | 2021-2023 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $116.28 | 2021-2025 | Glassia, Hyqvia |
| Merck Sharp & Dohme LLC | $104.93 | 2021-2025 | Winrevair, Keytruda |
| Sanofi-Aventis U.S. LLC | $94.95 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $89.48 | 2021-2022 | |
| Electromed, INC. | $86.52 | 2021-2024 | Smartvest |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $79.61 | 2022-2025 | Acthar |
| Pfizer INC. | $69.30 | 2022-2024 | |
| Insmed, INC. | $65.75 | 2024-2025 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $61.59 | 2021-2024 | |
| Mylan Specialty L.P. | $58.62 | 2021-2023 | Yupelri |
| Inspire Medical Systems, INC. | $55.57 | 2025 | Inspire |
| Harmony Biosciences LLC | $54.88 | 2023 | Wakix |
| Philips North America LLC | $50.69 | 2022-2023 | |
| Verona Pharma, INC. | $47.83 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $37.06 | 2021 | |
| Baxter Healthcare | $34.67 | 2023 | Hillrom - Life 2000 Ventilation System |
| Axsome Therapeutics, INC. | $32.82 | 2023 | Sunosi |
| Astellas Pharma US INC | $18.67 | 2023 | Cresemba |
| Vanda Pharmaceuticals INC. | $18.45 | 2021 | |
| Bard Peripheral Vascular, INC. | $18.32 | 2025 | Pleurx |
| Avadel Cns Pharmaceuticals, LLC | $18.25 | 2024 | Lumryz |
| Inogen, INC. | $18.14 | 2022 | |
| Advanced Respiratory, INC | $17.67 | 2021 | |
| Phadia US INC. | $15.05 | 2024 | Immunocap |
| Covis Pharma Gmbh | $14.59 | 2022 | |
| Eisai INC. | $14.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Sabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.